Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt

Ahmad N Fasseeh^{1

2}, Nada Korra³, Baher Elezbawy², Amal S Sedrak^{4

5}, Mary Gamal⁵, Randa Eldessouki⁶, Mariam Eldebeiky⁵, Mohsen George⁷, Ahmed Seyam⁷, Asmaa Abourawash⁸, Ahmed Y Khalifa⁹, Mayada Shaheen¹⁰, Sherif Abaza², Zoltán Kaló^{11

12}

Affiliations

¹ Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
² Syreon Middle East, Alexandria, Egypt.
³ Syreon Middle East, Alexandria, Egypt. nada.korra@syreon.eu.
⁴ Department of Public Health, Cairo University, Cairo, Egypt.
⁵ Egyptian Authority for Unifed Procurement, Medical Supply and Technology Management, Cairo, Egypt.
⁶ Department of Community Health, Fayoum University, Fayoum, Egypt.
⁷ Universal Health Insurance Authority, Cairo, Egypt.
⁸ Egyptian Drug Authority, Cairo, Egypt.
⁹ World Health Organization Representative Office, Cairo, Egypt.
¹⁰ Roche, Cairo, Egypt.
¹¹ Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
¹² Syreon Research Institute, Budapest, Hungary.

Published Erratum

Ahmad N Fasseeh et al. J Egypt Public Health Assoc. 2024.

. 2024 Dec 4;99(1):32.

doi: 10.1186/s42506-024-00178-4.

¹ Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
² Syreon Middle East, Alexandria, Egypt.
³ Syreon Middle East, Alexandria, Egypt. nada.korra@syreon.eu.
⁴ Department of Public Health, Cairo University, Cairo, Egypt.
⁵ Egyptian Authority for Unifed Procurement, Medical Supply and Technology Management, Cairo, Egypt.
⁶ Department of Community Health, Fayoum University, Fayoum, Egypt.
⁷ Universal Health Insurance Authority, Cairo, Egypt.
⁸ Egyptian Drug Authority, Cairo, Egypt.
⁹ World Health Organization Representative Office, Cairo, Egypt.
¹⁰ Roche, Cairo, Egypt.
¹¹ Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
¹² Syreon Research Institute, Budapest, Hungary.

No abstract available

Erratum for

Framework for developing cost-effectiveness analysis threshold: the case of Egypt.
Fasseeh AN, Korra N, Elezbawy B, Sedrak AS, Gamal M, Eldessouki R, Eldebeiky M, George M, Seyam A, Abourawash A, Khalifa AY, Shaheen M, Abaza S, Kaló Z. Fasseeh AN, et al. J Egypt Public Health Assoc. 2024 Jun 3;99(1):12. doi: 10.1186/s42506-024-00159-7. J Egypt Public Health Assoc. 2024. PMID: 38825614 Free PMC article.

Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in Egypt.
Radwan H, Fayed ZY, Elserry T, Alkarras MT, Shalash A, Shehata ZH, Noureldin NW, Metry A, Basha AK. Radwan H, et al. Appl Health Econ Health Policy. 2025 Aug 25. doi: 10.1007/s40258-025-00999-0. Online ahead of print. Appl Health Econ Health Policy. 2025. PMID: 40853538

1. Fasseeh AN, et al. Framework for developing cost-effectiveness analysis threshold: the case of Egypt. J Egypt Public Health Assoc. 2024;99:12. 10.1186/s42506-024-00159-7. - PMC - PubMed